Information about the rules and regulations that govern interactions between pharmaceutical, bioscience, medical device company, and other life sciences company interactions with physicians and other healthcare professionals. This includes information on the Sunshine Act, state laws, the PhRMA Code, and the AdvaMed Code on Ethical Interactions with Healthcare Professionals.
Now that the Sunshine Act is becoming operational, pharma meeting managers are learning exactly how to comply daily. Test yourself with these real-life scenarios!
Audit prep expert Lisa Keilty, CMP, HCC, president /owner of the pharma compliance consulting firm PMC2 (Professional Meeting Compliance Connection), explored what the OIG is looking for, and how pharma planners can prepare for an audit, during a...
The Sunshine Act provisions of the Affordable Care Act are here to stay. A compliance expert opened the 2013 Pharma Forum in Orlando with a detailed look at what meeting professionals at pharmaceutical and other life sciences and medical device...
The automatic spending cuts demanded by the sequestration that kicked in March 1 go across the federal healthcare agencies. How will they affect continuing medical education and pharmaceutical meetings? Here are some possibilities.
Survey reveals what doctors know, and don't know, about the Sunshine Act's transparency requirements, from the law's existence to what needs to be tracked and publicly reported. The upshot? Pharmaceutical companies and continuing...
